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Background: Antibiotic resistance is a major health problem, as drugs that were once highly effective no longer
cure bacterial infections. WGS has previously been shown to be an alternative method for detecting horizontally
acquired antimicrobial resistance genes. However, suitable bioinformatics methods that can provide easily inter-
pretable, accurate and fast results for antimicrobial resistance associated with chromosomal point mutations
are still lacking.
Methods: Phenotypic antimicrobial susceptibility tests were performed on 150 isolates covering three different
bacterial species: Salmonella enterica, Escherichia coli and Campylobacter jejuni. The web-server ResFinder-2.1
was used to identify acquired antimicrobial resistance genes and two methods, the novel PointFinder (using
BLAST) and an in-house method (mapping of raw WGS reads), were used to identify chromosomal point muta-
tions. Results were compared with phenotypic antimicrobial susceptibility testing results.
Results: A total of 685 different phenotypic tests associated with chromosomal resistance to quinolones, polymyxin,
rifampicin, macrolides and tetracyclines resulted in 98.4% concordance. Eleven cases of disagreement between
tested and predicted susceptibility were observed: two C. jejuni isolates with phenotypic fluoroquinolone resistance
and two with phenotypic erythromycin resistance and five colistin-susceptible E. coli isolates with a detected pmrB
V161G mutation when assembled with Velvet, but not when using SPAdes or when mapping the reads.
Conclusions: PointFinder proved, with high concordance between phenotypic and predicted antimicrobial sus-
ceptibility, to be a user-friendly web tool for detection of chromosomal point mutations associated with anti-
microbial resistance.
Introduction
Horizontal gene transfer among bacterial isolates is often con-
sidered the main mediator of acquired antimicrobial resistance.
However, mutational resistance is another important way to con-
fer resistance.
It has previously been shown that WGS can be an alternative
to phenotypic susceptibility testing of bacterial isolates for detec-
tion of horizontally acquired resistance.1,2 Databases for mapping
to chromosomal mutations have also been developed for
Mycobacterium tuberculosis.3 However, at present there is a lack
of suitable bioinformatics methods to provide easily interpretable
results for antimicrobial resistance associated with chromosomal
point mutations for most bacterial species.
In this study, a novel web tool, PointFinder, was developed for
detection of chromosomal point mutations associated with anti-
microbial resistance, in bacterial WGS data. PointFinder may be run
in parallel and become an extension to the already existing web
server tool ResFinder,1 which detects horizontally acquired resist-
ance genes in WGS data. The performance was compared with
that of an in-house mapping method for detecting point muta-
tions and both results were compared with phenotypic antimicro-
bial susceptibility tests in order to validate the possibilities of using
these methods as alternatives to standard phenotypical testing.
VC The Author 2017. Published by Oxford University Press on behalf of the British Society for Antimicrobial Chemotherapy.
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Materials and methods
Chromosomal mutation database
Information regarding mutations in chromosomal genes associated with
antimicrobial resistance was collected from published papers (Table 1).
The reference sequences were selected from WT Escherichia coli strain
K-12 (MG1655) for the E. coli database, Salmonella Typhimurium strain LT2
for the Salmonella enterica database and Campylobacter jejuni NCTC 11168
for the C. jejuni database.
Bacterial isolates and WGS data
In total, 150 isolates covering three species were included in the study:
E. coli (n"50) and Salmonella (n"50) isolates from the in-house strain col-
lection at the National Food Institute and C. jejuni (n"50) isolates from the
in-house strain collection at Statens Serum Institut. The isolates were
selected on the basis of having both WGS data and phenotypes available.
The Salmonella isolates included strains from 10 different serovars (Tables
S1 to S3, available as Supplementary data at JAC Online). All bacterial iso-
lates were sequenced using the Miseq platform (Illumina) to obtain paired-
end sequences and assembled de novo using Velvet (reference software).
Bacterial strains were screened for phenotypic resistance using MIC
determinations interpreted according to EUCAST (www.eucast.org). Only
the susceptibility tests relevant for antimicrobial resistance associated with
chromosomal point mutations for each species were analysed (Table 2).
As resistance to some of the antimicrobial agents can be caused by either
acquired genes or chromosomal point mutations, ResFinder-2.1 (www.
genomicepidemiology.org)31 was used to detect known acquired resist-
ance genes in the WGS data, using a threshold of 98% identity (%ID) and
60% length (minimum percentage length of the resistance gene to be cov-
ered). All isolates with disagreement between the phenotypic and pre-
dicted susceptibility were re-tested.
PointFinder
PointFinder consists of two databases: a chromosomal gene database, with
all reference sequences in fasta format; and a chromosomal mutation
database containing information on codon positions and substitutions.
PointFinder uses BLASTn for identifying the best match for each gene in the
chromosomal gene database, and only hits with an identity of 80% are
further analysed. The program goes through each alignment comparing
each position for the query (sequence found in input sequence) with the
corresponding position in the subject (database sequence). All mismatches
are saved and compared with the chromosomal mutation database. It is
Table 1. Overview of chromosomal point mutations for each species included in the database
Species Gene Chromosomal mutations Resistance Reference(s)
E. coli gyrA A51V, A67S, G81C, D82G, S83L, S83W, S83A, S83V, S83I, A84P, A84V, D87N, D87G,
D87Y, D87H, D87V, Q106H, Q106R, A196E
quinolone 4
gyrB R136L, R136C, R136H, R136S, R136G, R136I, R136E, D426N, K447E quinolone 4,5
parC A56T, S57T, F60I, F60L, G78D, G78K, S80R, S80I, S80L, S80Y, S80F, E84G, E84K, E84V,
E84A, A108V, A108T
quinolone 4,6,7
parE L416F, G423R, P439S, I444F, S458T, E460D, E460K, I464F, I470M, D475E, D476N,
I529L
quinolone 4,6,7
pmrA S39I, R81S colistin 8
pmrB V161G colistin 8
folP P63R, P64L, P64S, P64A, P64H sulphonamides 9
rpoB V146F, Q513L, Q513P, H526Y, R529C, R529S, S531F, L533P, T563P, P564L, R687H rifamycin 10
23Sa A2059G macrolide 11
16S rrsBa A523C, G527T, C528T, G1064T, G1064C, G1064A, C1066T, G1068A spectinomycin 12–15
16S rrsBa A964G, G1053A, C1054T, A1055G, G1058C tetracycline 13,16
16S rrsBa T1406A, A1408G gentamicin 17
16S rrsCa A794G, A794T, G926A, G926T, G926C, A1519G, A1519C, A1519T kasugamycin 18
16S rrsHa C1192T spectinomycin 19
S. enterica gyrA A67P, D72G, V73I, G81C, G81S, G81H, G81D, D82G, D82N, S83Y, S83F, S83A, D87N,
D87G, D87Y, D87K, L98V, A119S, A119E, A119V, A131G, E139A
quinolone 4
gyrB Y421C, R438L, S464Y, S464F, E466D quinolone 4,20
parC T66I, G78D, S80R, S80I, E84K, E84G quinolone 4,21
parE M438I, E454G, S458P, V461G, H462Y, A499T, V514G, V521F quinolone 4,20,22
pmrA G15R, G53E, G53R, R81C, R81H colistin 23
pmrB L22P, S29R, T92A, P94Q, E121A, S124P, N130Y, T147P, R155P, T156P, T156M, V161M,
V161L, V161G, E166K, M186I, G206W, G206R, S305R
colistin 23
16S rrsDa C1065T, C1192T spectinomycin 24
C. jejuni gyrA A70T, D85T, T86I, T86A, T86K, T86V, D90A, D90N, D90T, P104S quinolone 25–28
23Sa A2074G, A2074T, A2074C, A2075G macrolide 28
cmeR A86G macrolide 29
rplV A103C macrolide 29
rpsL K88E, K88R, K88Q spectinomycin 30
arRNA gene, mutation shown in DNA.
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possible for users to select whether they want to see all mismatches or only
known mismatches found in positions from the chromosomal database. In
this study we have only looked at mismatches found in positions known to
confer resistance, and thus specified in the database.
Mapping method
The fastq files corresponding to the paired-end reads were mapped against
the chromosomal gene sequence database using the assimpler.py script
described in Joensen et al.32 In brief, 17mers from the reads were mapped to
the reference sequence and extended to ungapped alignments that were
considered significant if they had a score of at least 50, using a match score
of 1 and a mismatch score of#3. A base was called if Z" (X# Y)/(X! Y) was
.3.29, where X is the number of observations of the most common nucleo-
tide and Y is the number of other nucleotides at that position. Furthermore,
nucleotide calls were considered significant only when the most common
nucleotide was at least 10 times more abundant than other nucleotides at
the position. All mismatches in positions from the chromosomal mutation
database were outputted except silent mutations, which were discarded. In
cases with disagreement between PointFinder and mapping, the isolates
were re-assembleddenovousing SPAdes33 and re-analysed by PointFinder.
Results
MIC and predicted antimicrobial resistance
The 150 isolates were each tested against four to six different anti-
microbial agents (Table 2), leading to a total of 684 susceptibility
test results (Tables S1–S3). These results were compared with the re-
sults from PointFinder, mapping and ResFinder. Resistance to colis-
tin, sulphonamides, tetracycline, erythromycin and spectinomycin
can be caused by both chromosomal point mutations and acquired
resistance genes; therefore results from both PointFinder and
ResFinder were used to explain resistance.
For all Salmonella isolates, complete agreement between
tested and predicted susceptibility was observed (Tables S1–S3).
Disagreements in E. coli and C. jejuni were observed in five and four
cases, respectively (Table 3).
The point mutation pmrB V161G was found by PointFinder in
five E. coli isolates (E30–E34), but all tested phenotypically suscep-
tible to colistin (MIC 1 mg/L). In C. jejuni, two isolates (C23 and
C39) tested phenotypically resistant to ciprofloxacin (MIC 8)
and nalidixic acid (MIC .64 mg/L), while two (C8 and C24) tested
erythromycin resistant (MIC .128 mg/L), but neither mutations
nor acquired genes were found that could explain the resistance.
PointFinder versus mapping
Mapping and PointFinder found the same mutations in all isolates
except the five pmrB V161G mutations found by PointFinder in
E. coli strains (E30–E34). The five isolates were re-assembled de
novo using SPAdes33 and run through PointFinder, and this time no
mutations were found in pmrB in any of the isolates. The codon
change detected in the Velvet assembly of the five isolates was
GTG!GGG, and when looking further into the sequences, the map-
ping showed that 28%–37% (Table 4) of the reads mapping to
pmrB contained GGG instead of GTG.
Discussion
This study showed a high agreement between phenotypic suscep-
tibility tests and WGS-predicted resistance, with only 11 (1.6%)
mismatches. However, since the number of isolates included in the
evaluation was very limited and selected, this has to be further
verified in future studies. The six disagreements observed in
C. jejuni all involved predicted susceptibility, whereas the isolates
were phenotypically resistant, which may be due to unknown
novel genes or mutations, as neither ResFinder nor PointFinder can
detect novel resistance mechanisms.
We found that the BLAST-based method was dependent on
the assembly method, which can cause either false-positive or
-negative results. As the mapping method does not depend on the
assembly this method gives a more precise result, which is consist-
ent with a recent study by Clausen et al.34 Exploring the sequences
mapping to pmrB, we found that1/3 of the isolate sequences for
Table 2. Antimicrobial agents used for susceptibility tests for each
species
Species Antimicrobial agents
E. coli ciprofloxacin, nalidixic acid, colistin, sulphonamide, tetra-
cycline, spectinomycin
Salmonella ciprofloxacin, nalidixic acid, colistin, spectinomycin
C. jejuni ciprofloxacin, nalidixic acid, erythromycin, spectinomycin
Acquired resistance genes, chromosomal point mutations or both can
cause resistance to antimicrobial agents.
Table 3. Disagreements between phenotypic and predicted resistance
Predicted genotype Conventional test
No. of isolates Isolate IDPointFinder mapping ResFinder resistant susceptible
pmrB V161G – – – CIP, NAL, CST, SMX, TET 4 E30, E32, E33, E34
pmrB V161G – tet(B) TET CIP, NAL, CST, SMX 1 E31
– – – ERY CIP, NAL, SPE 1 C8
– – – CIP, NAL ERY, SPE 2 C23, C39
gyrA T86I, gyrA P104S gyrA T86I, gyrA P104S – CIP, NAL, ERY SPE 1 C24
CIP, ciprofloxacin; CST, colistin; ERY, erythromycin; NAL, nalidixic acid; SMX, sulphonamide; TET, tetracycline; SPE, spectinomycin.
Bold, mismatch between predicted and conventional results.
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each isolate contained the V161G mutation, indicating that there
may be more than one copy of the pmrB gene present or that
the sequence consisted of more than a single isolate. For many
professionals working with WGS data, assemblies are still the
preferred format. Due to their smaller size, assemblies are easier
to share, upload and manage. Therefore, users working with
assembly-based methods should consider that the data quality
and method of assembly might influence the output.
Both ARG-ANNOT35 and CARD36 have tried to incorporate
chromosomal point mutations in their databases. ARG-ANNOT has a
database with partial sequences for chromosomal mutational re-
gions of genes associated with mutational resistance, as well as in-
formation about position and mutation in the corresponding gene.
ARG-ANNOT does not automatically detect these mutations, so the
user has to manually browse through the alignment to detect poten-
tial mutations. CARD’s resistance gene identifier (RGI) protein variant
models use curated SNP matrices to detect and report mutations
associated with resistance.37 Unfortunately, neither ARG-ANNOT nor
CARD takes the bacterial species into account. This means that both
methods also output possible mutations/sequences related to muta-
tional resistance, which is not relevant for the bacteria in question.
The user must therefore have prior knowledge of which mutational
genes and specific mutations they are looking for in order to use
these methods. To cope with some of these problems, we have de-
veloped PointFinder, with the purpose of facilitating user-friendly de-
tection of chromosomal point mutations associated with resistance.
In addition to being user friendly, the output from the web tool is eas-
ily understandable, reporting the detected mutations, nucleotide
and amino acid codon changes, predicted resistance and links to
papers describing the detected mutations. In the current version this
covers mutations conferring resistance to quinolones, macrolides
and polymyxin in E. coli, Salmonella and C. jejuni, but will be de-
veloped continuously with additional species.
Conclusions
This study showed a high concordance between phenotypic anti-
microbial susceptibility and predicted genotype by ResFinder and
PointFinder from WGS data. PointFinder is a user-friendly method
for detection of chromosomal point mutations associated with
antimicrobial resistance.
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